Li Jiang

Dr. Li Jiang


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 November 2023 in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Verified
Journal Article
Closed access
KSKe Shi
Ke Shi
JZJianda Zhou
Jianda Zhou
MLMan Li
Man Li
WYWenguang Yan
Wenguang Yan
JZJiaqi Zhang
Jiaqi Zhang
LJLi Jiang
Li Jiang


29 April 2026 in Lasers in Medical Science
Verified
Journal Article
Open access
LZLiping Zhu
Liping Zhu
YZYanhua Zhou
Yanhua Zhou
YTYao Tong
Yao Tong
CZChengyu Zhou
Chengyu Zhou
LJLi Jiang
Li Jiang
XLXuhong Li
Xuhong Li
Proposed Mechanism of Radiofrequency (RF) Therapy for Stress Urinary Incontinence (SUI). Vaginal RF treatment delivers controlled thermal energy to the tissue. This stimulus is proposed to activate transforming growth factor-beta (TGF-β) signaling. TGF-β binding to its receptor leads to phosphorylation of Smad2 (P-Smad2) and its translocation into the nucleus. Within the nucleus, the activated Smad complex regulates gene expression, promoting the synthesis of type III collagen while inhibiting degradation pathways. This restoration of collagen architecture strengthens pelvic floor support, thereby improving urethral closure function and alleviating SUI. Created with BioRender.com The online version contains supplementary material available at 10.1007/s10103-026-04879-4.

1 March 2026 in Clinical Epidemiology
Verified
Journal Article
Open access
PDF file
YXYuting Xu
Yuting Xu
CLChuanna Liu
Chuanna Liu
RNRuixing Nan
Ruixing Nan
AMAlvaro Munoz
Alvaro Munoz
LJLi Jiang
Li Jiang
Purpose: Ectopic pregnancy (EP) is a significant contributor to maternal mortality, posing a major burden on women in developing countries. This study examined global trends in EP mortality from 1982 to 2021, focusing on developing nations represented by BRICS countries (Brazil, Russian Federation, India, China, and South Africa). Methods: Based on the Global Burden Disease (GBD) 2021, an analysis of EP mortality was conducted by location (global and BRICS), age group (15– 49 years), and years (1982– 2021). The age-period-cohort (APC) model was utilized to estimate net drift, local drift, age effects, period effects, and cohort effects from 1982 to 2021. Furthermore, the Autoregressive Integrated Moving Average (ARIMA) model was employed to forecast EP mortality from 2022 to 2030. Results: Globally, the number of deaths due to EP reached 6442 (95% CI: 5368 to 7796) in 2021, representing a 55.08% increase compared with 1982. Despite rising absolute deaths, the global Age-Standardized Mortality Rate (ASMR) declined by 15.79%, reaching 0.16 per 100,000 population in 2021 (95% UI: 0.14 to 0.20), indicating a reduction in population-level risk after accounting for demographic structure. EP mortality predominantly affected individuals aged 20– 39 years across regions. APC analyses revealed distinct period and cohort effects, with marked heterogeneity across BRICS countries. Net Drift estimates ranged from a substantial annual decline in the Russian Federation (− 10.12%) to a modest decrease in India (− 1.62%), with Brazil, China, and South Africa showing intermediate downward trends. Conclusion: From 1982 to 2021, varying advancements in managing EP were observed among BRICS nations. Tailored financial allocations and policy measures aided in lowering EP mortality. Enhancing cross-country collaboration and knowledge exchange within BRICS countries is crucial for further ameliorating EP outcomes.